MedDataX Logo

VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients

NCT00394823 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 206

Last updated 2017-05-18

No results posted yet for this study

Summary

The purpose of this study is to assess the impact of supportive measures on the drug adherence of patients with essential hypertension

Conditions

  • Hypertension

Interventions

BEHAVIORAL

Set of supportive tools/measures vs. standard care

Sponsors & Collaborators

  • Novartis

    lead INDUSTRY

Principal Investigators

  • Novartis Basel · +41 61 324 1111

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • Germany
  • Switzerland

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00394823 on ClinicalTrials.gov